16401810

Source:http://linkedlifedata.com/resource/pubmed/id/16401810

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0524909, umls-concept:C0599724, umls-concept:C0909839
pubmed:issue	1
pubmed:dateCreated	2006-1-10
pubmed:abstractText	Emtricitabine is a nucleoside analogue approved for treatment of human immunodeficiency virus 1 with clinical activity against hepatitis B virus (HBV).
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/16401810-16401805
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0372440
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Alanine Transaminase, http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents, http://linkedlifedata.com/resource/pubmed/chemical/DNA, Viral, http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine, http://linkedlifedata.com/resource/pubmed/chemical/Hepatitis B Antibodies, http://linkedlifedata.com/resource/pubmed/chemical/emtricitabine
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	0003-9926
pubmed:author	pubmed-author:AndersonJaneJ, pubmed-author:ChanSingS, pubmed-author:Emtricitabine FTCB-301 Study Group, pubmed-author:GuanRichardR, pubmed-author:HusaPetrP, pubmed-author:KrastevZaharyZ, pubmed-author:KungNelsonN, pubmed-author:LeeSamuel SSS, pubmed-author:LimSeng GeeSG, pubmed-author:MondouElsaE, pubmed-author:NgTay MengTM, pubmed-author:RigneyAmyA, pubmed-author:RousseauFranckF, pubmed-author:ShiffmanMitchell LML, pubmed-author:SnowAndreaA, pubmed-author:SorbelJeffJ, pubmed-author:VolfovaMiroslavaM, pubmed-author:WashingtonMary KayMK
pubmed:issnType	Print
pubmed:day	9
pubmed:volume	166
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	49-56
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:16401810-Adult, pubmed-meshheading:16401810-Aged, pubmed-meshheading:16401810-Alanine Transaminase, pubmed-meshheading:16401810-Antiviral Agents, pubmed-meshheading:16401810-Biopsy, Needle, pubmed-meshheading:16401810-DNA, Viral, pubmed-meshheading:16401810-Deoxycytidine, pubmed-meshheading:16401810-Double-Blind Method, pubmed-meshheading:16401810-Female, pubmed-meshheading:16401810-Genotype, pubmed-meshheading:16401810-Hepatitis B, Chronic, pubmed-meshheading:16401810-Hepatitis B Antibodies, pubmed-meshheading:16401810-Hepatitis B virus, pubmed-meshheading:16401810-Humans, pubmed-meshheading:16401810-Liver, pubmed-meshheading:16401810-Male, pubmed-meshheading:16401810-Middle Aged, pubmed-meshheading:16401810-Placebo Effect, pubmed-meshheading:16401810-Treatment Outcome, pubmed-meshheading:16401810-Viral Load
pubmed:year	2006
pubmed:articleTitle	A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B.
pubmed:affiliation	National University Hospital, Singapore.
pubmed:publicationType	Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study